보고서 요약(국문)

개요
글로벌 비실험실 기반 대마초 검사 시장은 2022년 XX백만 달러에 달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 기록하며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
"비실험실 기반 대마초 검사 시장"이란 기존 실험실 외부에서 수행할 수 있는 대마초 검사 절차 및 제품을 의미합니다. 소비자, 기업 및 정부 기관은 대마초 제품의 안전성, 품질 및 규정 준수를 보장하기 위해 이러한 기술을 자주 활용합니다.
휴대용 검사 장비와 가정용 검사 키트를 통해 편리하고 즉각적인 현장 검사가 가능해졌습니다. 이러한 접근성은 샘플을 실험실로 배송하는 데 드는 시간과 비용을 절감하여 소비자와 기업 모두에게 매력적입니다. 대마에서 추출한 CBD 시장은 성장하고 있으며, 법률 준수를 위해 제품의 THC(테트라하이드로칸나비놀) 함량을 확인하기 위한 비실험실 검사가 필수적입니다.

시장 동향: 주요 동인
건강상의 이점에 대한 인식 증가
전 세계적으로 증가하는 대마초 검사 수요는 이 분야 및 관련 산업의 사업에 새로운 성장 기회를 열어주고 있습니다. 이러한 전망을 조사함으로써 기업과 잠재 투자자는 경쟁에서 앞서 나갈 수 있습니다. 최근 몇 년 동안 대마초에 함유된 다양한 물질, 특히 THC(테트라하이드로칸나비놀)와 CBD(칸나비디올)와 같은 칸나비노이드의 잠재적인 건강상의 이점에 대한 이해가 눈에 띄게 높아졌습니다.
대마초 유래 제품을 사용하고 건강이 개선된 사람들의 이야기가 주류 언론에 보도되었습니다. 이러한 직접적인 경험담과 성공 사례는 인식을 높이는 데 도움이 되었습니다. 더 많은 지역에서 의료용 또는 오락용으로 대마초를 합법화하거나 비범죄화함에 따라 대마초와 그 잠재적인 건강상의 이점에 대한 관심이 높아졌습니다. 이로 인해 건강에 미치는 영향에 대한 더욱 솔직한 대화가 이루어지게 되었습니다.
대마초 및 그 건강상의 이점에 대한 정보 접근성이 향상되었습니다. 기업, 옹호 단체 및 조직들은 모두 고객에게 대마초의 잠재적 이점에 대해 알리기 위해 투자해 왔습니다.
제한된 정확도
정확도 측면에서 비실험실 기반 테스트 절차는 실험실 테스트만큼 정밀하지 못할 수 있습니다. 다양한 용도에 적합함에도 불구하고 일부 규제 준수 요건을 충족하는 데 필요한 정밀도를 제공하지 못할 수 있습니다. 비실험실 기반 테스트 솔루션은 지역별로 통일된 규정이 없기 때문에 다양하고 변화하는 시장의 요구를 충족하기 어려울 수 있습니다.
세분화 분석
전 세계 비실험실 기반 대마초 테스트 시장은 테스트 방법, 적용 분야 및 지역별로 세분화됩니다.
가정용 테스트 키트 부문은 시장 점유율의 약 54.7%를 차지했습니다.
대마초 가정용 테스트 키트는 사용자와 소규모 대마초 재배자가 집에서 편안하게 대마초 제품의 효능, 안전성 및 품질을 평가할 수 있도록 제작되었습니다. 이 키트는 소비자가 섭취하는 대마초에 대한 유용한 정보, 예를 들어 테르펜 프로필, 살충제 및 중금속과 같은 오염 물질, 그리고 식물에 함유된 칸나비노이드(THC 및 CBD 등)의 양에 대한 정보를 제공합니다.
중독이 시작되기 전에 예방하는 것이 약물 남용을 줄이는 가장 효과적인 전략입니다. 집에서 안전하게 실시할 수 있는 약물 검사는 어린이, 청소년 또는 사랑하는 사람의 약물 사용 여부를 검사하는 안전하고 비침습적인 방법입니다. 간편하고 비접촉식인 가정용 약물 검사 키트로는 레디컵(Redi-Cup)이 있습니다. 결과는 5분 안에 확인할 수 있으며 이해하기 쉽습니다.
영국 홈헬스(Home Health)는 11세에서 25세 사이의 사람들이 가장 많이 사용하는 물질이 대마초임을 밝혔습니다. 당사의 원스텝 대마초 검사는 평균 최대 30일 동안 대마초를 검출할 수 있으며, 민감도는 20ng입니다.
이 제품은 10회 검사 팩으로 구성되어 있으며, 검사 민감도는 20ng/mL입니다. 유럽 직장 약물 검사 협회(EWDTS) 기준을 충족하는 당사의 약물 검사 민감도를 제공합니다. 약물은 사용 후 약 7일에서 30일 동안 체내에 남아 측정 가능합니다. 모든 검사는 99%의 정확도를 자랑하며 CE 인증을 획득했습니다.
지역 분석
북미는 시장 점유율의 약 45.6%를 차지했습니다.
북미는 전 세계 비실험실 기반 대마초 검사 시장에서 지배적인 위치를 차지하고 있습니다. 미국은 주별로 대마초 관련 규정이 있으며, 각 주마다 고유한 규칙이 있습니다. 판매 적합성을 보장하기 위해 주에서 요구하는 검사 항목 또한 다양합니다. 이러한 제약에도 불구하고 미국 시장은 전 세계에서 가장 큰 규모와 판매량을 기록하고 있습니다.
이는 대마초 검사 서비스에 대한 높은 수요를 시사합니다. 잠재적인 측면에서 볼 때, 기업은 가장 큰 잠재력을 가진 미국 시장으로 확장하기 전에 연방 규정 하에서 경험과 규모를 확보할 수 있는 해외 시장에서 대마초 검사 역량을 먼저 개발하는 것을 고려해야 합니다.

휴대용 테스트 기기와 가정용 테스트 키트에 대한 수요는 CBD와 같은 칸나비노이드의 잠재적인 건강상의 이점에 대한 소비자 인식이 높아지고 제품 안전 및 품질의 중요성이 부각됨에 따라 증가했습니다.
미국의 여러 주에서 의료용 대마초 관련 정책을 시행하고 있으며, 환자들은 적절한 복용량을 정하고 치료 효과를 평가하기 위해 정확한 효능 테스트에 의존하고 있습니다.
COVID-19 영향 분석
2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업, 특히 비실험실 기반 대마초 테스트 시장에 전례 없는 어려움을 초래했습니다. 팬데믹으로 인해 안전에 대한 소비자의 우려와 정확한 제품 정보에 대한 필요성이 증가했습니다. 그 결과, 특히 오락용 및 의료용으로 구매하는 대마초 제품의 합법성을 확인하려는 사람들이 늘어나면서 가정용 테스트 키트 시장이 급증했습니다.
비실험실 기반 테스트는 대마초를 평가할 수 있는 비접촉식의 실용적인 방법을 제공했기 때문에 소비자는 더 이상 물리적인 테스트 시설을 방문할 필요가 없었습니다. 이는 특히 봉쇄와 사회적 거리두기 기간 동안 매우 유용했습니다.
테스트 방법별
• 휴대용 테스트 장치
o 살충제 테스트기
o 효능 테스트기
o 테르펜 테스트기
o 수분 및 수분 활성도 테스트기
• 가정용 테스트 키트
o 가정용 THC 테스트 키트
o 신속 살충제 검출 키트
o 가정용 미생물 테스트 키트
적용 분야별
• 의료용 대마초
• 기호용 대마초
• 헴프 제품
• 대마초 함유 식품
• 대마초 음료
• 국소 도포 제품
• 흡입 제품
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Purple Scientific, Orange Photonic Inc. 등이 있습니다. Gemmacert, MyDx Inc., tCheck, ALPHA-CAT, Sage Analytics Inc., PharmLabs LLC, CannaSafe, Steep Hill 등이 포함됩니다.

보고서 구매 이유:

• 테스트 방법, 적용 분야 및 지역별 글로벌 비실험실 기반 대마초 테스트 시장 세분화를 시각화하고 주요 상업 자산 및 플레이어를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 비실험실 기반 대마초 테스트 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석 결과를 PDF 보고서로 제공합니다.

• 주요 플레이어의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 비실험실 기반 대마초 테스트 시장 보고서는 약 53개의 표, 50개의 그림, 186페이지로 구성됩니다.

2023년 목표 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The Global Non-Laboratory-based Cannabis Testing Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
The term "non-laboratory-based cannabis testing market" describes cannabis testing procedures and products that can be carried out outside of a conventional laboratory. Customers, companies, and government agencies frequently utilize these techniques to guarantee the security, excellence, and adherence to regulations of cannabis products.
Convenient, on-the-spot testing is made possible by portable testing equipment and home testing kits. This accessibility lowers the time and expense involved in shipping samples to a laboratory, making it appealing to both consumers and corporations. The market for CBD generated from hemp is growing, and in order to stay in compliance with the law, non-laboratory testing is now required to verify the THC(tetrahydrocannabinol) content of goods.
Market Dynamics: Drivers
Rising Awareness of Health Benefits
Growing cannabis testing demand globally is opening up new growth opportunities for businesses in this and related industries. By investigating these prospects, organizations and potential investors can get a jump start on the competition. In recent years, there has been a notable trend toward increased understanding of the potential health advantages of various substances present in cannabis, especially cannabinoids like THC (tetrahydrocannabinol) and CBD (cannabidiol).
Narratives of people who have used cannabis-derived products and seen improvements in their health have been published by mainstream media outlets. These first-hand accounts and success stories have helped raise awareness. Cannabis and its possible health benefits have gained increased attention as more areas legalize or decriminalize it for either medical or recreational use. More candid conversations concerning its impact on health have resulted from this.
Public access to information regarding cannabis and its health advantages has increased. Businesses, advocacy groups, and organizations have all made investments to inform customers about the possible benefits of cannabis.
Limited Accuracy
When it comes to accuracy, non-laboratory-based testing procedures could not be as precise as laboratory testing. They might not offer the precision needed to meet some regulatory compliance requirements, despite being appropriate for a variety of uses. Non-laboratory-based testing solutions may find it difficult to satisfy the varied and changing needs of various markets due to the absence of uniform rules across areas.
Segment Analysis
The global non-laboratory-based cannabis testing market is segmented based on testing method, application and region.
The home testing kits segment accounted for approximately 54.7% of the market share
Cannabis home testing kits are made to enable users and small-scale cannabis farmers to evaluate the strength, safety, and quality of cannabis products in the comfort of their own homes. These kits give consumers useful information about the cannabis they are ingesting, like terpene profiles, possible contaminants like pesticides and heavy metals, and the amount of cannabinoids (like THC and CBD) in the plant.
Preventing addiction before it begins is the most effective strategy to reduce substance misuse; drug tests, when administered in the privacy of one's own home, are a safe and non-intrusive way to test children, adolescents, or loved ones for drug use. A straightforward, contact-free drug test is the Redi-Cup at-home drug test. The results can be accessed in five minutes and are simple to understand.
UK's Home Health provides the most widely used substance among individuals aged 11 to 25 is cannabis. Our One-Step Cannabis Test can identify cannabis for up to 30 days on average, with a sensitivity of 20ng.
The products come with a 10-test pack and a test sensitivity of 20 ng/mL. The European Workplace Drug Testing Society (EWDTS) criteria are met by our drug test sensitivities. About 7 to 30 days are the approximate measurable times it stays in the body after use. All tests have a 99% accuracy level and are CE-certified.
Geographical Analysis
North America accounted for approximately 45.6% of the market share
North America has been a dominant force in the global non-laboratory-based cannabis testing market. The United States has state-level regulations on cannabis, and each state has its own set of rules. Tests required by the state to guarantee that goods are suitable for sale also vary. Despite there being some limitations, the US market continues to be the largest globally, with the highest volume of sales.
This indicates a matching need for cannabis testing services. In terms of potential, that implies businesses should think about developing cannabis capabilities first in foreign markets where they may gain experience and scale under federal rules before expanding into US states where the biggest prospects are found.
The need for portable testing devices and home testing kits has been fueled by growing consumer awareness of the possible health benefits of cannabinoids like CBD as well as the significance of product safety and quality.
Numerous states in the United States have implemented medical cannabis initiatives, and patients depend on precise potency testing to establish the right dosage and evaluate the effectiveness of their treatment.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global non-laboratory-based cannabis testing market. Customers' worries about safety and the need for accurate product information increased as a result of the pandemic. As a result, there was a sharp increase in the market for home testing kits as people looked to confirm the legitimacy of the cannabis products they were buying, particularly for recreational and medicinal purposes.
Customers no longer needed to attend physical testing facilities because non-laboratory-based testing offered a contactless and practical means for them to evaluate their cannabis. This was especially helpful during lockdowns and social distancing.
By Testing Method
• Portable Testing Devices
o Pesticide Testers
o Potency Testers
o Terpene Testers
o Moisture and Water Activity Testers
• Home Testing Kits
o At-Home THC Test Kits
o Quick Pesticide Detection Kits
o Home Microbial Test Kits
By Application
• Medical Cannabis
• Recreational Cannabis
• Hemp Products
• Cannabis Edibles
• Cannabis Beverages
• Topical Products
• Inhalable Products
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Purple Scientific, Orange Photonic Inc., Gemmacert, MyDx Inc., tCheck, ALPHA-CAT, Sage Analytics Inc., PharmLabs LLC, CannaSafe, and Steep Hill among others.
Why Purchase the Report?
• To visualize the global non-laboratory-based cannabis testing market segmentation based on testing method, application and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of non-laboratory-based cannabis testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global non-laboratory-based cannabis testing market report would provide approximately 53 tables, 50 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Testing Method
3.2. Snippet by Application
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Awareness of Health Benefits
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Limited Accuracy
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Testing Method
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Method
7.1.2. Market Attractiveness Index, By Testing Method
7.2. Portable Testing Devices*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Pesticide Testers
7.2.4. Potency Testers
7.2.5. Terpene Testers
7.2.6. Moisture and Water Activity Testers
7.3. Home Testing Kits
7.3.1. At-Home THC Test Kits
7.3.2. Quick Pesticide Detection Kits
7.3.3. Home Microbial Test Kits
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Medical Cannabis*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Recreational Cannabis
8.4. Hemp Products
8.5. Cannabis Edibles
8.6. Cannabis Beverages
8.7. Topical Products
8.8. Inhalable Products
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Method
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Method
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Method
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Method
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Testing Method
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Purple Scientific*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Orange Photonic Inc.
11.3. Gemmacert
11.4. MyDx Inc.
11.5. tCheck
11.6. ALPHA-CAT
11.7. Sage Analytics Inc.
11.8. PharmLabs LLC
11.9. CannaSafe
11.10. Steep Hill
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

Purple Scientific, 4.	Key Developments, Orange Photonic Inc., Gemmacert, MyDx Inc., tCheck, ALPHA-CAT, Sage Analytics Inc., PharmLabs LLC, CannaSafe, Steep Hill

표 목록 (Tables)

List of Tables

Table 1 Global Non-Laboratory-based Cannabis Testing Market Value, By Testing Method, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Non-Laboratory-based Cannabis Testing Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Non-Laboratory-based Cannabis Testing Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Non-Laboratory-based Cannabis Testing Market Value, By Testing Method, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Non-Laboratory-based Cannabis Testing Market Value, By Testing Method, 2022-2031 (US$ Million)

Table 6 Global Non-Laboratory-based Cannabis Testing Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Non-Laboratory-based Cannabis Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 8 Global Non-Laboratory-based Cannabis Testing Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Non-Laboratory-based Cannabis Testing Market Value, By Region, 2022-2031 (US$ Million)

Table 10 North America Non-Laboratory-based Cannabis Testing Market Value, By Testing Method, 2022-2031 (US$ Million)

Table 11 North America Non-Laboratory-based Cannabis Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 12 North America Non-Laboratory-based Cannabis Testing Market Value, By Country, 2022-2031 (US$ Million)

Table 13 South America Non-Laboratory-based Cannabis Testing Market Value, By Testing Method, 2022-2031 (US$ Million)

Table 14 South America Non-Laboratory-based Cannabis Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 15 South America Non-Laboratory-based Cannabis Testing Market Value, By Country, 2022-2031 (US$ Million)

Table 16 Europe Non-Laboratory-based Cannabis Testing Market Value, By Testing Method, 2022-2031 (US$ Million)

Table 17 Europe Non-Laboratory-based Cannabis Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 18 Europe Non-Laboratory-based Cannabis Testing Market Value, By Country, 2022-2031 (US$ Million)

Table 19 Asia-Pacific Non-Laboratory-based Cannabis Testing Market Value, By Testing Method, 2022-2031 (US$ Million)

Table 20 Asia-Pacific Non-Laboratory-based Cannabis Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 21 Asia-Pacific Non-Laboratory-based Cannabis Testing Market Value, By Country, 2022-2031 (US$ Million)

Table 22 Middle East & Africa Non-Laboratory-based Cannabis Testing Market Value, By Testing Method, 2022-2031 (US$ Million)

Table 23 Middle East & Africa Non-Laboratory-based Cannabis Testing Market Value, By Application, 2022-2031 (US$ Million)

Table 24 Purple Scientific: Overview

Table 25 Purple Scientific: Product Portfolio

Table 26 Purple Scientific: Key Developments

Table 27 Orange Photonic Inc.: Overview

Table 28 Orange Photonic Inc.: Product Portfolio

Table 29 Orange Photonic Inc.: Key Developments

Table 30 Gemmacert: Overview

Table 31 Gemmacert: Product Portfolio

Table 32 Gemmacert: Key Developments

Table 33 MyDx Inc.: Overview

Table 34 MyDx Inc.: Product Portfolio

Table 35 MyDx Inc.: Key Developments

Table 36 tCheck: Overview

Table 37 tCheck: Product Portfolio

Table 38 tCheck: Key Developments

Table 39 ALPHA-CAT: Overview

Table 40 ALPHA-CAT: Product Portfolio

Table 41 ALPHA-CAT: Key Developments

Table 42 Sage Analytics Inc.: Overview

Table 43 Sage Analytics Inc.: Product Portfolio

Table 44 Sage Analytics Inc.: Key Developments

Table 45 PharmLabs LLC: Overview

Table 46 PharmLabs LLC: Product Portfolio

Table 47 PharmLabs LLC: Key Developments

Table 48 CannaSafe: Overview

Table 49 CannaSafe: Product Portfolio

Table 50 CannaSafe: Key Developments

Table 51 Steep Hill: Overview

Table 52 Steep Hill: Product Portfolio

Table 53 Steep Hill: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 2 Global Non-Laboratory-based Cannabis Testing Market Share, By Testing Method, 2022 & 2031 (%)

Figure 3 Global Non-Laboratory-based Cannabis Testing Market Share, By Application, 2022 & 2031 (%)

Figure 4 Global Non-Laboratory-based Cannabis Testing Market Share, By Region, 2022 & 2031 (%)

Figure 5 Global Non-Laboratory-based Cannabis Testing Market Y-o-Y Growth, By Testing Method, 2022-2031 (%)

Figure 6 Portable Testing Devices Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 7 Home Testing Kits Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 8 Global Non-Laboratory-based Cannabis Testing Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 9 Medical Cannabis Application in Global Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 10 Recreational Cannabis Application in Global Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 11 Hemp Products Application in Global Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 12 Cannabis Edibles Application in Global Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 13 Cannabis Beverages Application in Global Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 14 Topical Products Application in Global Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 15 Inhalable Products Application in Global Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 16 Global Non-Laboratory-based Cannabis Testing Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 17 North America Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 18 Asia-Pacific Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 19 Europe Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 20 South America Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 21 Middle East and Africa Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 22 North America Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 23 North America Non-Laboratory-based Cannabis Testing Market Share, By Testing Method, 2022 & 2031 (%)

Figure 24 North America Non-Laboratory-based Cannabis Testing Market Share, By Application, 2022 & 2031 (%)

Figure 25 North America Non-Laboratory-based Cannabis Testing Market Share, By Country, 2022 & 2031 (%)

Figure 26 South America Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 27 South America Non-Laboratory-based Cannabis Testing Market Share, By Testing Method, 2022 & 2031 (%)

Figure 28 South America Non-Laboratory-based Cannabis Testing Market Share, By Application, 2022 & 2031 (%)

Figure 29 South America Non-Laboratory-based Cannabis Testing Market Share, By Country, 2022 & 2031 (%)

Figure 30 Europe Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 31 Europe Non-Laboratory-based Cannabis Testing Market Share, By Testing Method, 2022 & 2031 (%)

Figure 32 Europe Non-Laboratory-based Cannabis Testing Market Share, By Application, 2022 & 2031 (%)

Figure 33 Europe Non-Laboratory-based Cannabis Testing Market Share, By Country, 2022 & 2031 (%)

Figure 34 Asia-Pacific Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 35 Asia-Pacific Non-Laboratory-based Cannabis Testing Market Share, By Testing Method, 2022 & 2031 (%)

Figure 36 Asia-Pacific Non-Laboratory-based Cannabis Testing Market Share, By Application, 2022 & 2031 (%)

Figure 37 Asia-Pacific Non-Laboratory-based Cannabis Testing Market Share, By Country, 2022 & 2031 (%)

Figure 38 Middle East & Africa Non-Laboratory-based Cannabis Testing Market Value, 2022-2031 (US$ Million)

Figure 39 Middle East & Africa Non-Laboratory-based Cannabis Testing Market Share, By Testing Method, 2022 & 2031 (%)

Figure 40 Middle East & Africa Non-Laboratory-based Cannabis Testing Market Share, By Application, 2022 & 2031 (%)

Figure 41 Purple Scientific: Financials

Figure 42 Orange Photonic Inc.: Financials

Figure 43 Gemmacert: Financials

Figure 44 MyDx Inc.: Financials

Figure 45 tCheck: Financials

Figure 46 ALPHA-CAT: Financials

Figure 47 Sage Analytics Inc.: Financials

Figure 48 PharmLabs LLC: Financials

Figure 49 CannaSafe: Financials

Figure 50 Steep Hill: Financials

글로벌 비실험실 기반 대마초 검사 시장 – 2023-2030

Global Non-Laboratory-based Cannabis Testing Market - 2023-2030